000 | 01749 a2200469 4500 | ||
---|---|---|---|
005 | 20250513031657.0 | ||
264 | 0 | _c19950615 | |
008 | 199506s 0 0 eng d | ||
022 | _a1055-9965 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpitz, M R | |
245 | 0 | 0 |
_aMutagen sensitivity as a biological marker of lung cancer risk in African Americans. _h[electronic resource] |
260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cMar 1995 |
||
300 |
_a99-103 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenocarcinoma _xepidemiology |
650 | 0 | 4 | _aBlack or African American |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 |
_aBlack People _xgenetics |
650 | 0 | 4 |
_aBleomycin _xadverse effects |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xepidemiology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xepidemiology |
650 | 0 | 4 |
_aLymphocytes _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMutagens _xadverse effects |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSmoking _xepidemiology |
650 | 0 | 4 |
_aTexas _xepidemiology |
700 | 1 | _aHsu, T C | |
700 | 1 | _aWu, X | |
700 | 1 | _aFueger, J J | |
700 | 1 | _aAmos, C I | |
700 | 1 | _aRoth, J A | |
773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 4 _gno. 2 _gp. 99-103 |
|
999 |
_c7537455 _d7537455 |